Navigation Links
Shire Delivers Strong First Quarter Performance and Reiterates its Expectation of Good Full Year Earnings Growth
Date:4/26/2012

All trademarks designated ® and ™ used in this press release are trademarks of Shire plc or companies within the Shire group except for 3TC® and ZEFFIX® which are trademarks of GSK, PENTASA® which is a registered trademark of FERRING B.V., FABRAZYME® and CEREZYME® which are trademarks of Genzyme Corporation, CONCERTA® which is a trademark of ALZA Corporation and DAYTRANA® which is a trade mark of Noven Pharmaceuticals Inc. Certain trademarks of Shire plc or companies within the Shire group are set out in Shire's Annual Report on Form 10-K for the year ended December 31, 2011.

For further information please contact:

Investor Relations        
  - Eric Rojas    erojas@shire.com    +1-781-482-0999
  - Sarah Elton-Farr    seltonfarr@shire.com     +44-1256-894-157
Media        
  - Jessica Mann (Corporate)    jmann@shire.com    +44-1256-894-280
  - Gwen Fisher (Specialty Pharma)    gfisher@shire.com     +1-484-595-9836
  - Jessica Cotrone (Human Genetic Therapies)    jcotrone@shire.com    +1-781-482-9538
  - Lindsey Hart (Regenerative Medicine)    lhart@abh.com    +1-615-250-3311


'/>"/>
SOURCE Shire plc
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25

Related medicine technology :

1. Shire Strives to Increase Adherence Among Chronic Kidney Disease Stage 5 Patients
2. Shire Enhances its Orphan Drug Pipeline With the Acquisition of a New Clinical Candidate for Metachromatic Leukodystrophy
3. Shire to Present Additional Scientific Data on ADHD Treatment Portfolio at American Psychiatric Association Annual Meeting
4. Shires Investigational Nonstimulant ADHD Treatment INTUNIV(TM) (Guanfacine Extended Release) Demonstrated Significant Efficacy in Reducing ADHD Symptoms at All Measured Time Points Up to 24 Hours Postdose
5. Shire Announces Approval of ELAPRASE(R) (idursulfase) in Brazil
6. Shire to add New Orphan Drug to its HGT Portfolio - EU Launch Imminent
7. Shire Withdraws European Application for DAYTRANA(TM) (Methylphenidate Transdermal System)
8. Shire Announces Study Results of the Effects of INTUNIV(TM) (Guanfacine) Extended Release on Secondary Measures in Children with ADHD and Oppositional Symptoms
9. Shire Presented Results of a New Database Analysis on Lialda(R) (Mesalamine) and Other 5-ASAs for Ulcerative Colitis at Digestive Disease Week
10. Shire has Filed a Treatment Protocol for Velaglucerase Alfa for Gaucher Disease
11. Shire Receives Fast Track Designation for velaglucerase alfa for Gaucher Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/1/2015)... LOUIS , July 1, 2015 New ... first quarter of 2015 compared to the same time ... the Express Scripts (NASDAQ: ESRX ) Exchange Pulse™ ... first quarter of 2014, the number of new exchange ... declined 18 percent in the first quarter of 2015. ...
(Date:6/30/2015)... EDINBURGH, Scotland , July 1, 2015 ... joins Nu C ana team   ... proprietary ProTide technology to develop and commercialise a portfolio ... Professor Chris McGuigan as Chief Scientific Officer. ... the ProTide technology. He is currently Professor of Medicinal ...
(Date:6/30/2015)... , June 30, 2015 Nortek Security ... NTK ) and a leader in the ... today announced it acquired mobile personal emergency response ... held Numera, Inc. Headquartered in ... easily implemented, mobile PERS products and cloud-based software ...
Breaking Medicine Technology:Express Scripts Provides First Look at 2015 Public Exchange Pharmacy Trends 2Express Scripts Provides First Look at 2015 Public Exchange Pharmacy Trends 3Express Scripts Provides First Look at 2015 Public Exchange Pharmacy Trends 4Express Scripts Provides First Look at 2015 Public Exchange Pharmacy Trends 5Internationally Renowned Medicinal Chemist Professor Chris McGuigan Appointed as NuCana's Chief Scientific Officer 2Internationally Renowned Medicinal Chemist Professor Chris McGuigan Appointed as NuCana's Chief Scientific Officer 3Nortek Security & Control Acquires Health and Wellness Technology Business from Numera 2Nortek Security & Control Acquires Health and Wellness Technology Business from Numera 3Nortek Security & Control Acquires Health and Wellness Technology Business from Numera 4
... 2, 2010 Fiscal first quarter revenue from ... $641 million Fiscal first quarter adjusted income from ... $0.87 per share Fiscal first quarter GAAP income ... per share Rx segment revenue grew 47 percent ...
... IRVINE, Calif., Nov. 2, 2010 Endologix, Inc. (Nasdaq: ... for aortic disorders, announced today the first clinical implant ... City Hospital in Auckland, New Zealand.  The procedure was ... of Interventional Radiology) and Andrew, Hill, MD (Associate Professor ...
Cached Medicine Technology:Perrigo Reports Record Earnings and Raises Full Year Adjusted EPS Guidance 2Perrigo Reports Record Earnings and Raises Full Year Adjusted EPS Guidance 3Perrigo Reports Record Earnings and Raises Full Year Adjusted EPS Guidance 4Perrigo Reports Record Earnings and Raises Full Year Adjusted EPS Guidance 5Perrigo Reports Record Earnings and Raises Full Year Adjusted EPS Guidance 6Perrigo Reports Record Earnings and Raises Full Year Adjusted EPS Guidance 7Perrigo Reports Record Earnings and Raises Full Year Adjusted EPS Guidance 8Perrigo Reports Record Earnings and Raises Full Year Adjusted EPS Guidance 9Perrigo Reports Record Earnings and Raises Full Year Adjusted EPS Guidance 10Perrigo Reports Record Earnings and Raises Full Year Adjusted EPS Guidance 11Perrigo Reports Record Earnings and Raises Full Year Adjusted EPS Guidance 12Perrigo Reports Record Earnings and Raises Full Year Adjusted EPS Guidance 13Perrigo Reports Record Earnings and Raises Full Year Adjusted EPS Guidance 14Perrigo Reports Record Earnings and Raises Full Year Adjusted EPS Guidance 15Perrigo Reports Record Earnings and Raises Full Year Adjusted EPS Guidance 16Perrigo Reports Record Earnings and Raises Full Year Adjusted EPS Guidance 17Perrigo Reports Record Earnings and Raises Full Year Adjusted EPS Guidance 18Perrigo Reports Record Earnings and Raises Full Year Adjusted EPS Guidance 19Endologix Announces First Clinical Implant of Ventana™ Stent Graft 2Endologix Announces First Clinical Implant of Ventana™ Stent Graft 3Endologix Announces First Clinical Implant of Ventana™ Stent Graft 4
(Date:7/1/2015)... ... ... B. E. Smith, the only full-service leadership solutions firm dedicated exclusively to ... for Capital Health in Pennington, N.J. One of the top ... more than 1,000 healthcare executives into organizations. , Capital Health is a two-hospital ...
(Date:7/1/2015)... ... July 01, 2015 , ... Who doesn’t want a life filled with ... a healthy balance between work and life, and positive friendships and relationships? , ... Health: Flourishing Lives, Wellbeing in Doctors. , With a focus on solving the epidemic ...
(Date:7/1/2015)... ... July 01, 2015 , ... METTLER ... line. With larger-than-average weighing pans, ML-T balances give operators the room they need ... this extra real estate makes ML-T balances a perfect choice for day-to-day weighing ...
(Date:7/1/2015)... (PRWEB) , ... July 01, 2015 , ... ... dedicated to the global distribution and marketing of a number of nutritional and ... when it attended the 2015 ECRM Diet, Vitamin & Sports Nutrition conference in ...
(Date:7/1/2015)... , ... July 01, 2015 ... ... the communities of southeast Alabama, southwest Georgia and the Florida Panhandle, the ... as its primary secure text messaging and clinical communications workflow solution provider. ...
Breaking Medicine News(10 mins):Health News:Capital Health Retains B. E. Smith to Recruit New Chief Nursing Officer 2Health News:Capital Health Retains B. E. Smith to Recruit New Chief Nursing Officer 3Health News:Medical Doctor Explains The Healthy Effects of a Positive Outlook in New Book 2Health News:METTLER TOLEDO Launches Compact ML-T Balances: Larger Pan Offers Greater Weighing Flexibility in Tight Spaces 2Health News:NPI Executives Report Great Success at ECRM Conference 2Health News:Southeast Alabama Community Health System Chooses TelmedIQ to Meet Secure Text Messaging Challenges for Healthcare 2
... 2008: Adalimumab therapy is effective and well-tolerated in ... arthritis (PsA) patients with a previously inadequate response ... infliximab, according to results of research presented today ... Rheumatology in Paris, France. This positive response to ...
... China, June 12 /Xinhua-PRNewswire-FirstCall/ -- China Sky One,Medical, ... Medical," "CSY"), a manufacturer,marketer and distributor of pharmaceutical, ... that it has signed an agreement to,acquire Peng ... established,pharmaceutical company that has obtained Good Manufacturing Practice,Certification ...
... Biogen Idec will present data on baminercept alfa ... LIGHT pathway inhibitor in development for the treatment ... the 2008 European League Against Rheumatism (EULAR) Annual ... de Congrs de Paris. Three abstracts will be ...
... Va., June 12 Millions of,Americans are suffering ... struggling with tough economic times, according to a ... alarming new survey,results, patients may wish to consider ... prevention of stress-related headaches and muscle,pain, says the ...
... A few months ago, members of,Congress asked the Social ... approaching retirement age. "A lot of seniors had the,idea ... Cameron,Truesdell, CEO of LTC Financial Partners LLC (LTCFP), one ... insurance agencies. "It wasn,t,so, but the wording of the ...
... history of chronic insomnia in parents is not only ... elevated risks for use of hypnotics, psychopathology and suicidal ... that will be presented on Thursday at SLEEP 2008, ... Societies (APSS). , The study, authored by Xianchen Liu, ...
Cached Medicine News:Health News:Adalimumab therapy effective in AS, RA and PsA patients refractory to other anti-TNF therapies 2Health News:China Sky One Medical, Inc. to Acquire Peng Lai Jin Chuang Company 2Health News:China Sky One Medical, Inc. to Acquire Peng Lai Jin Chuang Company 3Health News:Biogen Idec's baminercept alfa shows promise in patients with rheumatoid arthritis 2Health News:Biogen Idec's baminercept alfa shows promise in patients with rheumatoid arthritis 3Health News:Biogen Idec's baminercept alfa shows promise in patients with rheumatoid arthritis 4Health News:Chiropractic Can Offer Relief from Stress-Related Pain, Health Problems 2Health News:Social Security Statement Advises Seniors to Consider Private Long-Term Care Insurance, LTC Agency Reports; Medicare Won't Cover It 2Health News:Insomnia in parents can result in sleep problems, suicidal behavior among their offspring 2
...
... QUANTA LiteTM ANA is an enzyme-linked ... of anti-nuclear antibodies (ANA) in human serum. ... in conjunction with clinical findings and other ... of rheumatic diseases such as systemic lupus ...
... Immuno Concepts manufactures slides that are ... technologist to decrease the number of pipetting ... patient sample dilutions on the slides. Ask ... procedure and these slides. These slide formats ...
... The ANA and ENA assays can ... negative for antinuclear antibodies, which are ... such as Systemic lupus erythematosus (Lupus), ... progressive systemic sclerosis, scleroderma, polymyositis, dermatomyositis, ...
Medicine Products: